[
1. Hillbertz NS, Hirsch JM, Jalouli J, Jalouli MM, Sand L. Viral and molecular aspects of oral cancer. Anticancer Res. 2012;32(10):4201-12.
]Search in Google Scholar
[
2. Deng Z, Uehara T, Maeda H, Hasegawa M, Matayoshi S, Kiyuna A, et al. Epstein-Barr virus and human papillomavirus infections and genotype distribution in head and neck cancers. PLoS One. 2014; 9(11):e113702.10.1371/journal.pone.0113702
]Search in Google Scholar
[
3. IARC Monographs on the evaluation of carcinogenic risks to humans. Epstein-Barr Virus and Kaposi’s Sarcoma Herpesvirus/Human Herpesvirus 8. International Agency for Research on Cancer: Lyon, France; 1997:47-262.
]Search in Google Scholar
[
4. Jácome AA, Lima EM, Kazzi AI, Chaves GF, Mendonça DC, Maciel MM, et al. Epstein-Barr virus-positive gastric cancer: a distinct molecular subtype of the disease? Rev Soc Bras Med Trop. 2016; 49(2):150-7.10.1590/0037-8682-0270-2015
]Search in Google Scholar
[
5. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517): 202-9.10.1038/nature13480
]Search in Google Scholar
[
6. Fołtyn S, Strycharz-Dudziak M, Drop B, Boguszewska A, Polz-Dacewicz M. Serum EBV antibodies and LMP-1 in Polish patients with oropharyngeal and laryngeal cancer. Infect Agent Cancer. 2017; 12:31.10.1186/s13027-017-0141-x
]Search in Google Scholar
[
7. Diaz Orea MA, Muñoz Perez V, Gómez Conde E, Castellanos Sánchez VO, Gonzalez Lopez R, Flores Alonso JC, et al. Expression of Cytokines Interleukin-2, Interleukin-4, Interleukin-10 and Transforming Growth Factor β in Gastric Adenocarcinoma Biopsies Obtained from Mexican Patients. Asian Pac J Cancer Prev. 2017;18(2): 577-82.
]Search in Google Scholar
[
8. Neves M, Marinho-Dias J, Ribeiro J, Esteves M, Maltez E, Baldaque I, et al. Characterization of Epstein-Barr virus strains and LMP1-deletion variants in Portugal. J Med Virol.2015;87(8):1382-88.10.1002/jmv.24190
]Search in Google Scholar
[
9. Camargo MC, Murphy G, Koriyama C, Pfeiffer RM, Kim WH, Herrera-Goepfert R, Corvalan AH, et al. Determinations of Epstein-Barr virus-positive gastric cancer: an international pooled analysis. Br J Cancer. 2011;105(1):38-43.10.1038/bjc.2011.215
]Search in Google Scholar
[
10. Wang A, Zhang W, Jin M, Zhang J, Li S, Tong F, et al. Differential expression of EBV proteins LMP-1 and BHFR1 in EBV-associated gastric and nasopharyngeal cancer tissues. Mol Med Rep. 2016;13(5): 4151-58.10.3892/mmr.2016.5087
]Search in Google Scholar
[
11. Mori S, Itoh T, Tokunaga M, Eizuru Y. Deletions and single-base mutations within the carboxy-terminal region of the latent membrane protein 1 oncogene in Epstein-Barr virus-related gastric cancers of Southern Japan. J Med Virol. 1999;57(2):152-8.10.1002/(SICI)1096-9071(199902)57:2<152::AID-JMV11>3.0.CO;2-K
]Search in Google Scholar
[
12. Tsao SW, Tsang CM, To KF, Lo KW. The role of Epstein-Barr virus in epithelial malignancies. J Pathol. 2015;235(2):323-33.10.1002/path.4448
]Search in Google Scholar
[
13. Shukla SK, Khatoon J, Prasad KN, Rai RP, Singh AK, Kumar S, et al. Transforming growth factor beta 1 (TGFβ-1) modulates Epstein-Barr virus reactivation in absence of Helicobacter pylori infection in patients with gastric cancer. Cytokine. 2016;77:176-9.10.1016/j.cyto.2015.07.023
]Search in Google Scholar
[
14. Căinap SS, Fetică B, Buiga R, Căinap C, Constantin AM, Şovrea AS. The prognostic role of EBER in pediatric cancer. Rom J Morphol Embroyol. 2015;56(4):1269-77.
]Search in Google Scholar
[
15. Lamberdt SL, Martinez OL. Latent membrane protein 1 of EBV activates phosphatidylinositol 3-kinase to induce production of IL-10. J Immunol. 2007;179(12):8225-34.10.4049/jimmunol.179.12.8225
]Search in Google Scholar
[
16. Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev. 2008;226:205-18.10.1111/j.1600-065X.2008.00706.x
]Search in Google Scholar
[
17. Ng TH, Britton GJ, Hill EV, Verhagen J, Burton BR, Wraith DC. Regulation of adaptive immunity; the role of interleukin-10. Front Immunol. 2013;4:129.
]Search in Google Scholar
[
18. Chao Y, Jing Y, Jia Y, Wang Y, Zhao C, Luo B. Conservation and mutation of viral interleukin-10 gene in gastric carcinomas and nasopharyngeal carcinomas. J Med Virol. 2011;83(4):644-50.10.1002/jmv.22091
]Search in Google Scholar
[
19. McKenzie J, Lopez-Giraldez F, Delecluse HJ, Walsh A, El-Guindy A. The Epstein-Barr virus immunoevasins BCRF1 and BPLF1 are expressed by a mechanism independent of the canonical late preinitiation complex. PLOS Pathogens. 2016;12(11):e1006008.10.1371/journal.ppat.1006008
]Search in Google Scholar
[
20. De Vita F, Orditura M, Galizia G, Romano C, Infusino S, Auriemma A, et al. Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies. Cancer. 1999;86(10):1936-43.10.1002/(SICI)1097-0142(19991115)86:10<1936::AID-CNCR9>3.0.CO;2-9
]Search in Google Scholar
[
21. Pachnia D, Drop B, Dworzańska A, Kliszczewska E, Polz-Dacewicz M. Transforming Growth Factor-β, Interleukin-10, and Serological Markers in EBV-associated Gastric Carcinoma. Anticancer Res. 2017;37(9):4853-8.
]Search in Google Scholar
, 